SCHEMBL30877154

SCHEMBL30877154

O=C(O)NC1CCCCCCCCC1.c1cnn(-c2cn[nH]c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
KAT7 O95251 1/20 0.37
CHRM1 P11229 1/20 0.36
RAB9A P51151 1/20 0.36
ACKR3 P25106 1/20 0.36
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35
KMT2A Q03164 3/20 0.35
POLB P06746 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
MEN1 O00255 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
HDAC4 P56524 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30877147 0.92 CHRM1 (0.34) SMN1; SMN2ALDH1A1TSHRKAT7CHRM1
SCHEMBL370948 0.76 NOTUM (0.46) ALDH1A1KMT2AGAAMAPTMEN1
SCHEMBL15106549 0.68 CHRM1 (0.41) CHRM1CNR1HDAC4
SCHEMBL15106553 0.68 CHRM1 (0.41) CHRM1CNR1HDAC4
SCHEMBL14392512 0.66 LMNA (0.59) ALDH1A1KMT2AMEN1CYP1A2CYP2C19
SCHEMBL23329154 0.65 CD38 (0.54) ALDH1A1TSHRKAT7RAB9ACNR1
SCHEMBL4886377 0.65 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1TSHRRAB9AACKR3
SCHEMBL6617905 0.65 HTT (0.44) SMN1; SMN2ALDH1A1TSHRRAB9AMAPT
SCHEMBL529370 0.65 EPHX1 (0.67) SMN1; SMN2ALDH1A1RAB9AGAAMAPT
SCHEMBL4017458 0.65 EPHX1 (0.67) SMN1; SMN2ALDH1A1RAB9AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117964628-A Macrocyclic compounds as CDK9 inhibitors and application thereof 科辉智药生物科技(深圳)有限公司 2024-05-03 CN disclosed
WO-2024088189-A1 MACROCYCLIC COMPOUND AS CDK9 INHIBITOR AND USE THEREOF 科辉智药生物科技(无锡)有限公司 2024-05-02 WO disclosed